Cutler Group’s Achieve Life Sciences ACHV Stock Holding History

Cutler Group’s Portfolio ACHV Stock Details ACHV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,600	Closed	-$1K	–	3717
2023 Q2	$1K	Buy	2,600 +1,600	+160%	+$11.2K	﹤0.01%	3170
2023 Q1	$2K	Buy	+1,000	New	+$4.75K	﹤0.01%	3061

Other funds holding ACHV

Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

JGC

J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return

Cutler Group's ACHV Position: Q4 2023 in Review

Cutler Group sold out of Achieve Life Sciences (ACHV) in Q4 2023, closing a stake of 479 shares — an estimated $2K sold.

Cutler Group first reported a position in ACHV in Q4 2015 and held it in 9 quarters. The position peaked at $25K in Q4 2015. 30 funds tracked by Wall St. Rank hold ACHV as of Q4 2023.

Cutler Group reported no remaining Achieve Life Sciences position as of Q4 2023 after selling out during the quarter.
Cutler Group sold 479 Achieve Life Sciences shares in Q4 2023, an estimated $2K.
Cutler Group first reported a position in Achieve Life Sciences in Q4 2015 and held it in 9 quarters.
Cutler Group's Achieve Life Sciences position peaked at $25K in Q4 2015.
30 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q4 2023.

Based on Cutler Group's 13F filing for Q4 2023, filed 18 Jan 2024.